CHICAGO (Reuters) – Women who take oral contraceptives run a higher risk of developing cervical cancer, but this risk is transient and reverts to normal about 10 years after they stop, British researchers said on Thursday. Other studies have found a link between taking the pill and cervical cancer, but this is the first to show how long this risk persists, according to the study in the journal Lancet….(Source)———————–
The Actuary, a professional magazine for actuaries in the U.K., published the article, “The Breast Cancer Epidemic,” discussing the impact of the epidemic in England and Wales for the life and health insurance and health care industries through 2029. The article was based on forecasts of breast cancer rates originally published last month in the Journal of American Physicians and Surgeons. The forecasts can be used to plan treatment facilities and calculate insurance premiums and reserves, as more insurance claims and litigation are expected. Patrick Carroll, a statistician and actuary, showed that abortion is the “best predictor” of breast cancer trends, and fertility is also a useful predictor. Carroll applied national data to a mathematical model that he has used in the past to successfully forecast breast cancer incidence. He expects an overall increase of 50.9% in the cancer rate in
England and Wales by 2029.
Other highlights include:
- The increasing rates of abortion and breast cancer run parallel and are highly correlated.
- The impact on insurers is more serious because women in the age group 45+ are claiming more highly paid posts.
- Abortion before first full term birth is “highly carcinogenic.”
- “Oestrogen (estrogen), progestin and other female hormones, whether naturally produced or administered medically, fuel breast cancer development,” said Carroll.
Carroll observed a reverse gradient. Upper class women have higher mortality and morbidity rates than do lower class women because they are more likely to choose abortion before a first birth in order to pursue higher educations and careers. “Breast cancer fundraising is likely to be very profitable for the American Cancer Society, Susan G. Komen for the Cure and others that continue to knowingly mislead women by denying the abortion-breast cancer link,” declared Karen Malec, president of the Coalition on Abortion/Breast Cancer. “But, the epidemic will be costly for the insurance industry and consumers, not to mention the cancer patients who will suffer because of the cancer fundraising industry’s misconduct.” (Source)
On this side of the fence, we’re all wondering when the dippy feminist clique will stop being shills for the abortion and pharmaceutical industries. Wouldn’t it be great to actually start to care about the lives of women instead of the sixties’ sexual revolution and the blood money it has generated?